Meet the new kid on the block Cryptococcus gattii Karen H. Bartlett, PhD Associate Professor School of Environmental Health.

Slides:



Advertisements
Similar presentations
Endemic or Outbreak? Differentiating recent transmission of an historic tuberculosis strain in New York City IUATLD-NAR 16 th Annual Meeting February 23-25,
Advertisements

Evaluation of the IMMY CrAg Lateral Flow Assay for Detection of Cryptococcal Antigen Susan Clarke and Robert Gibb Pathology Queensland – Central, Royal.
OPPORTUNISTIC FUNGAL INFECTIONS
Fungal Diseases March 24 th, Fungi fundamentals Occupy almost every ecological niche Exist in two forms: Yeasts –Single celled Molds –Growth in.
Disseminated Cryptococcosis in a Dog Presented by: Paul G. Gallagher Co-Authors: Natalie Durrett Crawford, Farrah B. Horowitz, D. Phillip Sponenberg Virginia-Maryland.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Cryptococcal pneumonia and meningitis. Cryptococcus neoformans.
Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.
Virology Program Program Head: Mel Krajden, Martin Petric Section Head: Annie Mak,Peggy Tsang VS Staff: 40 Research:  SARS  Influenza viruses  Gastroenteritis.
Mycology – Yeast Student Lab Division of Medical Technology Carol Larson MSEd, MT(ASCP)
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS Stephen J. Gluckman, M.D. Botswana-UPENN Partnership.
Vibrio species are present in The Great Bay, Durham, NH. All three species which are monitored, V. parahaemolyticus, V. vulnificus, and V. cholerae, were.
Fungi.
Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease.
Risk Factors for Oral Cancer Development in British Columbia: Lessons Learned from History CONCLUSIONS  This is the first step to examine this unique,
Epidemiology.
Health Disparities of Minority Women and Diabetes Kathleen M. Rayman, Ph.D., RN Appalachian Center for Translational Research in Disparities Faculty Development.
Cryptococcus neoformans and other Yeast Dr Sharon Walmsley University Health Network Toronto.
NEPAL IS ALSO KNOWN AS. The country of Mount Everest.
Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.
BLASTOMYCOSIS (Blastomyces dermatitidis)
Prattana Leenasirimakul
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Fungi (Chapter 28) “a group of diverse and widespread unicellular and multicellular organisms, lacking chlorophyll, usually bearing spores and often filamentous”
Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
Is West Nile Virus becoming World Wide Epidemic? Stephen Pereira PH.D Candidate Walden University PUBH Environmental Health Dr. Saran Tucker-Wilkins.
CANDIDA & CRYTOCOCCUS Prepared by: Miss Norzawani Jaffar Bsc (Hons) Biomedical Sciences, UKM Lecture 15.
neoformans causes cryptococcal meningitis. C neoformans is an oval, budding yeast surrounded by a wide polysaccharide.
Opportunistic Pathogens –Aspergillus species. Aspergillosis is an infection caused by Aspergillus, a common mold that lives indoors and outdoors. Most.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
1 |1 | Situation Update Influenza A (H1N1), 26 May 09.
Respiratory Fungal Infections-II Dr. Ahmed Al-Barrag Asst. Professor of Medical Mycology School of Medicine and the University Hospitals King Saud University.
Maria N. Gamaletsou 1,2, David Denning 1, and Nikolaos V. Sipsas 2 1 The National Aspergillosis Centre, University Hospital of South Manchester and The.
opportunistic Pathogens
The burden of serious fungal infections in Portugal Raquel Sabino 1, Cristina Verissímo C 1, Célia Pais 2, David W. Denning 3 1 Nacional Institute of Health.
Epidemiology. Epidemiological studies involve: –determining etiology of infectious disease –reservoirs of disease –disease transmission –identifying patterns.
CRYPTOCOCCOSIS PARACOCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS
Rabies surveillance in BC Melissa McLaws, DVM, PhD 14 th Zoonoses Symposium November 10, 2015.
Hospital-acquired Invasive Aspergillosis: How Big is the Problem?
Epidemiology. Epidemiology involves: –determining etiology of infectious disease –reservoirs of disease –disease transmission –identifying patterns associated.
THE USE OF PCR -RFLP OF THE PHOSPHOLIPASE B GENE FOR THE DIFFERENTIATION BETWEEN VARIETIES AND MOLECULAR TYPES WITHIN CRYPTOCOCCUS NEOFORMANS GEORGES NICOLAS.
Lecturer name: Dr. Ahmed M. Albarrag Lecture Date: Oct-2012 Lecture Title: Diversity of Fungi and Fungal Infections (Foundation Block, Microbiology)
Cryptococcus neoformans Basidiomycete yeast Both an opportunistic and a primary pathogen mainly affecting CNS Serotype D More frequent in Europe Serotype.
Cryptococcus gattii Fungal Meningitis
Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.
Communicable Diseases Alan J. Parkinson, Deputy Director Arctic Investigations Program, Centers for Disease Control & Prevention, USA.
MALDI TOF analysis of Streptococcus pneumoniae from Cerebrospinal Fluid for the diagnosis of Acute Bacterial Meningitis Dr. R. Ravikumar, M.D., Professor.
Dr.C.Vemulapalli, Dr.A.Krishnan, Dr.R.Jain,
Fungi in Tissue Lab-5-. Fungi in Tissue (con’t.) 1.) Yeasts: These vary in size, shape, method of dividing, with of without a capsule, etc. The following.
Estimated burden of fungal infections in Italy
Number of infections per underlying disorder per year
Burden of acute otitis media, recurrent otitis media and tympanostomy tube insertion in urban, minority children less than 7 years of age in Boston: Comparison.
Deep mycoses /systemic Mycoses
Mycology Lec. 5 Dr. Manahil
Cryptococcus neoformans infections
CRYPTOCOCCAL INFECTIONS IN PATIENTS WITH AIDS
Table 2. Cerebrospinal Fluid Analysis (CSF analysis)
J. Lemaire1, S. Jones1, S. Hale1 M. Hartwick1
Meningitis Surveillance and investigation of causes of altered mental status among Kamuzu Central Hospital admissions, Lilongwe, Malawi Charles Kyriakos.
Cryptococcosis: Treatment outcome
Diagnosis of Cryptococcal disease
Predominance of Cryptococcus neoformans var
Cryptococcus: Mycology and Virulence
Cryptococcosis: Epidemiology of cryptococcal disease
The Role of NICs in Influenza Surveillance
Cryptococcus: Mycology and Virulence
Diagnosis of Cryptococcal disease
Cryptococcosis: Epidemiology of cryptococcal disease
Cryptococcosis: Treatment outcome
Rooted neighbor-joining tree inferred from the concatenated MLST typing scheme sequences (CAP59, GPD1, LAC1, SOD1, URA5, and PLB1 genes and IGS) of 10.
Presentation transcript:

Meet the new kid on the block Cryptococcus gattii Karen H. Bartlett, PhD Associate Professor School of Environmental Health University of British Columbia University of British Columbia

The story as it unfolds … In 2001, veterinary lab first to notice  cases of cryptococcosis in pets on Vancouver Island In 2001, veterinary lab first to notice  cases of cryptococcosis in pets on Vancouver Island About the same time, medical microbiologist also finds  human cases … About the same time, medical microbiologist also finds  human cases …

What is cryptococcosis? Cryptococcus is an encapsulated yeast and opportunistic primary pathogen. Cryptococcus is an encapsulated yeast and opportunistic primary pathogen. Cryptococcosis is the infection …may involve lungs, CNS, or other organ systems. Cryptococcosis is the infection …may involve lungs, CNS, or other organ systems. Almost exclusively a disease of immunocompromised hosts. Almost exclusively a disease of immunocompromised hosts. It’s the fourth most common cause of life threatening infections in persons with AIDS. It’s the fourth most common cause of life threatening infections in persons with AIDS.

Typical cryptococcosis … Encapsulated yeast, can identify from microscope “Normally” associated with pigeons, world wide distribution

However!  cases on Vancouver Island were NOT in immunocompromised humans or animals  cases on Vancouver Island were NOT in immunocompromised humans or animals Cryptococcus isolates cultured from human cases were looked at again and subjected to serotyping Cryptococcus isolates cultured from human cases were looked at again and subjected to serotyping Surprise! The Cryptococcus from these British Columbia cases were serogroup B. Surprise! The Cryptococcus from these British Columbia cases were serogroup B.

Cryptococcus neoformans There are 4 serogroups of Cryptococcus neoformans that are pathogenic to mammals There are 4 serogroups of Cryptococcus neoformans that are pathogenic to mammals A and D are found world wide A and D are found world wide B and C are only supposed to be found in tropical or subtropical countries B and C are only supposed to be found in tropical or subtropical countries BUT … none of the new cases reported travel histories. BUT … none of the new cases reported travel histories.

VarietySerotypeMolecular type C. neoformans var. grubii AVN I VN II C. neoformans var. neoformans D VN IV Neoformans hybridAD VN III Cryptococcus gattiiBCBC VG I VG II VG III VG IV Relationship of pathogenic cryptococci

Outbreak … Annual incidence of all cryptococcosis (including AIDS associated) ~ 3-5/10 6 Annual incidence of all cryptococcosis (including AIDS associated) ~ 3-5/10 6 As of July 2001: As of July 2001: Humans (n=38) Pets (n=34) Porpoises (n=2) Incidence on Vancouver Island ~ 20/10 6 Incidence on Vancouver Island ~ 20/10 6

Outbreak …continues Annual incidence of all cryptococcosis (including AIDS associated) ~ 3-5/10 6 Annual incidence of all cryptococcosis (including AIDS associated) ~ 3-5/10 6 As of December 2008: As of December 2008: Humans (n=239) Pets (estimate = 3 – 4 times diagnosed human cases) Incidence on Vancouver Island ~ 24/10 6 Incidence on Vancouver Island ~ 24/10 6 Case fatality ratio 8.7 % (19 deaths) Case fatality ratio 8.7 % (19 deaths)

Objective: Identify Cryptococcus gattii

Objective: Identify Cryptococcus gattii Microscopic 1000x India ink or calcofluor white Capsule Budding yeast with narrow base

Objective: Identify Cryptococcus gattii Cryptococcal antigen latex agglutination - Very sensitive – 10 ng /mL biologic fluid - Positive serum test (1:4) probable infection - Positive test ≥ 1:8 active infection - Can be used to monitor effectiveness of tx - Serum (pretreat with pronase) -CSF (no pretreatment) Does not differentiate between C. gattii and C. neoformans

Objective: Identify Cryptococcus gattii Culture techniques: Primary plating as normal – Cryptococcus grows well on Sabouraud Dextrose Agar Colonies visible at 48 – 72 hr Optimal growth 30 – 35 o C (slower ≥ 37) Cream coloured, glistening or matte

Objective: Identify Cryptococcus gattii Add primary isolation media Bird Seed Agar or Caffeic Acid Agar (C. gattii = dark chocolate brown) (C. neoformans = milk chocolate brown)

Objective: Identify Cryptococcus gattii Confirmation agar: Canavanine-glycine-bromthymol blue (CGB) (C. gattii = grows & turns medium blue 24 h – 5 days) (C. neoformans = no growth, medium yellow or green)

Objective: Identify Cryptococcus gattii Physiological tests: C. neoformans and C. gattii are indistinguishable: Germ tube test negative Hydrolysis of urea positive (rapid test available) Growth on cycloheximide media negative Carbohydrate assimilation tests Caffeic Acid disk (rapid test available)

1 kb marker (Gibco-BRL) R634 R794 F2596 F2932 F3179 F MR10 1 kb marker (Gibco-BRL) F2863 F2866 F kb marker (Gibco-BRL) E113 ENV123 ENV124 ENV125 ENV129 ENV130 ENV131 ENV133 ENV152 ENV153 1 kb marker (Gibco-BRL) WM148 VNI Standard WM626 VNII Standard WM628 VNIII Standard WM629 VNIV Standard 1 kb marker (Gibco-BRL) WM179 VGI Standard WM178 VGII Standard WM161 VGIII Standard WM779 VGIV Standard 1 kb marker (Gibco-BRL) URA5-RFLP unique genotypes clinicalenvironmental Source: S. Kidd

URA5 - orotidine monophosphate pyrophosphorylase CAP59 - capsular associated protein GPD1- glyceraldehyde-3-phosphate dehydrogenase LAC1- laccase PLB1- phospholipase SOD1- superoxide dismutase IGS1- rRNA intergenic spacer C. gattii MLST genotyping scheme

Genotyping Cryptococcus at BCCDC Source: M. Morshed

Susceptibility testing Cryptococcus - Break points not established for crypto. - E-test used by many laboratories -Micro-broth dilution media not standardized (added glucose ±, shaking ±) - Fluconazole ± Ampho B for uncomplicated pulmonary 3 – 12 months

MIC µg/mL fluconzaole GenotypeRangeGeo MeanMIC 50 MIC 90 VG IIa2 – VG IIb4 – VG I & III0.5 – All0.5 – Susceptibility testing C. gattii Source: Dr. Shawn Lockhart Centers for Disease Control and Prevention

MIC µg/mL Amphotericin B GenotypeRangeGeo MeanMIC 50 MIC 90 VG IIa0.125 – VG IIb0.06 – VG I & III0.05 – All0.05 – Susceptibility testing C. gattii Source: Dr. Shawn Lockhart Centers for Disease Control and Prevention

Rates and demographics Incidence Incidence 236 cases 236 cases Mean 24.2 cases per year Mean 24.2 cases per year 25.1/million population Vancouver Island 25.1/million population Vancouver Island Demographics Mean age – 59 years Age range 2 – 92 y  4 pediatric cases  70 – 79 y highest incidence Male 56% Source: BC CDC 2008

Mortality 19 deaths (case fatality ratio of 8.7%) 19 deaths (case fatality ratio of 8.7%)  Underlying cause of death in 9; contributing cause in 10 Mean age at death: 67.6 (range 26 – 91y) Mean age at death: 67.6 (range 26 – 91y)  Cases who died were older than those who did not Median time from diagnosis to death: 54 days (range 5 – 577 d) Median time from diagnosis to death: 54 days (range 5 – 577 d) 12 (63.2%) had underlying medical conditions 12 (63.2%) had underlying medical conditions  6 cancer  3 COPD  2 liver disease  1 HIV, lung transplant, congestive heart failure, congenital heart malformation Cases who died were more likely to present with CNS disease Cases who died were more likely to present with CNS disease Source: Galanis 2008

Case-Control study 1999 – 2001 (n = 30) Risk factorsMatched OR95% CI Corticosteroids , Chronic lung disease , 9.52 Recurrent pneumonia , 6.98 Cancer , 6.81 Current or past smoker , 3.20 Diabetes , 2.50 Asthma , 1.66 Outdoor building repair , Woods within mile of house , 2.02 Camping , 2.91 Gardening , 2.79 Branch clean-up , 0.76 Cutting/chopping wood , 0.76 Pruning , 0.88 Source: MacDougall & Fyfe 2008

Population-based risk factors 1999 – 2007 (n = 218) Risk FactorPrevalence in C. gattii cases Prevalence in BC population P-value Age ≥ 50 years72.4%31.3%< Male55.8%49.6%0.198 Current smoker41.9%17.8%< Invasive cancer24.7%3.6%< HIV Infection3.7%0.2%< COPD4.1%8.0%0.09 Asthma3.4%7.8%0.54 Corticosteroids27.0%unknown Source: Galanis 2008

Environmental & host risk factors (canine) Source: Duncan 2006

Environmental & host risk factors (feline) Source: Duncan 2006

Airborne Cryptococcus by month

BC Host tree species

Tree swab by geographic location Tree LocationDistance from Victoria (km) Swabs examined Swabs positive % positive Campbell RiverN % CourtenayN % ParksvilleN % NanaimoN % CowichanN % Gulf IslandsE % Victoria353123% Distance from Parksville (km) Port AlberniW % West CoastW MainlandE

Cryptococcus in soil by geographic location LocationDistance from Victoria (km) nCFU/gram soil GM GSD Range Campbell RiverN CourtenayN – 4365 ParksvilleN – NanaimoN – 708 CowichanN – Gulf IslandsE – Victoria – 2042 Distance from Parksville (km) Port AlberniW – 537 MainlandE

Mobility of Cryptococcus Air Air Wood/sawdust Wood/sawdust Soil Soil Shoes Shoes Car tires/wheel wells Car tires/wheel wells Water Water

Mobility on car wheel wells

Environmental sampling: Mainland and beyond

Source: S. Mak 2010

Conclusions: Cryptococcus gattii is endemic on the east coast of Vancouver Island Cryptococcus gattii is endemic on the east coast of Vancouver Island Cultured from a wide range of native tree species Cultured from a wide range of native tree species Not homogeneous in the environment (hot spots) Not homogeneous in the environment (hot spots)

Conclusions: Human cases preceded by animal cases, veterinarians most likely to see sentinel cases Human cases preceded by animal cases, veterinarians most likely to see sentinel cases C. gattii mis-identified as C. neoformans if additional laboratory tests not performed C. gattii mis-identified as C. neoformans if additional laboratory tests not performed Multiple C. gattii genotypes in Cascadia Multiple C. gattii genotypes in Cascadia

Team Crypto once and future … Vancouver Vancouver  BC CDC  Epidemiology  L. MacDougall (ex), S. Mak, E. Galanis,  L. MacDougall (ex), S. Mak, E. Galanis, Colette Gaulin, Min Li  Laboratory  M. Moreshed, Min Lee, L. Hoang, S. Mithani  UBC Sarah Kidd (ex), Yat Chow, Jim KronstadSarah Kidd (ex), Yat Chow, Jim Kronstad

Team Crypto once and future … Vancouver Island Vancouver Island Victoria and Health Authorities Victoria and Health Authorities Pam Kibsey, Murray Fyfe Pam Kibsey, Murray Fyfe Centre for Coastal Health Centre for Coastal Health Craig Stephen, Colleen Duncan (ex) Craig Stephen, Colleen Duncan (ex) Animal surveillance Animal surveillance Central Laboratory (ex) Central Laboratory (ex) Canada West Critical Care (Vancouver) Canada West Critical Care (Vancouver)

Team Crypto once and future … Cryptococcus gattii working group of the Pacific Northwest Cryptococcus gattii working group of the Pacific Northwest Kieren Marr, Kausik Datta, Rebecca Baer, Edmond Byrnes, Joseph Heitman, Mira Leslie, Shelley Magill Kieren Marr, Kausik Datta, Rebecca Baer, Edmond Byrnes, Joseph Heitman, Mira Leslie, Shelley Magill CDC Cryptococcus group CDC Cryptococcus group Tom Chiller, Shawn Lockhart, Julie Harris, Ron Wohrle Tom Chiller, Shawn Lockhart, Julie Harris, Ron Wohrle

Acknowledgements: BC Lung Association BC Lung Association Michael Smith Foundation for Health Research Michael Smith Foundation for Health Research Sampling team members: Sampling team members: Yat Chow, Tracy Kirkham, Molly Chen, Hua Shen, Caroline Chen, Timothy Ma, Fred Rockwell Yat Chow, Tracy Kirkham, Molly Chen, Hua Shen, Caroline Chen, Timothy Ma, Fred Rockwell BC Parks employees, Vancouver Island EHOs BC Parks employees, Vancouver Island EHOs

Publications: in press or in preparation … Mak, S, Klinkenberg, B, Bartlett, K, Fyfe, M. (in press) Ecological Niche Modeling of Cryptococcus gattii in British Columbia, Canada. Environmental Health Perspectives 118 (5): Mak, S, Klinkenberg, B, Bartlett, K, Fyfe, M. (in press) Ecological Niche Modeling of Cryptococcus gattii in British Columbia, Canada. Environmental Health Perspectives 118 (5): Chapter: “The emergence of Cryptococcus gattii infections on Vancouver Island and expansion in the Pacific Northwest.” Karen Bartlett, Edmond Byrnes, Colleen Duncan, Murray Fyfe, Eleni Galanis, Joseph Heitman, Linda Hoang, Sarah Kidd, Laura MacDougall, Sunny Mak, Kieren Marr, Muhammad Morshed, Sarah West, and James Kronstad. In: Cryptococcus: from human pathogen to model yeast. Eds: J. Kwon-Chun and J. Heitman. ASM Press. Expected publication date Chapter: “The emergence of Cryptococcus gattii infections on Vancouver Island and expansion in the Pacific Northwest.” Karen Bartlett, Edmond Byrnes, Colleen Duncan, Murray Fyfe, Eleni Galanis, Joseph Heitman, Linda Hoang, Sarah Kidd, Laura MacDougall, Sunny Mak, Kieren Marr, Muhammad Morshed, Sarah West, and James Kronstad. In: Cryptococcus: from human pathogen to model yeast. Eds: J. Kwon-Chun and J. Heitman. ASM Press. Expected publication date Lester, S, Bartlett, K, and others 2010 A review of C. gattii cryptococcosis in the North American Pacific Northwest. Vet Clin Path Lester, S, Bartlett, K, and others 2010 A review of C. gattii cryptococcosis in the North American Pacific Northwest. Vet Clin Path

Datta, K. Bartlett, K, Baer, R, Byrnes, E, Galanis, E, Heitman, J, Hoang, L, Leslie, M, MacDougall, L, Magill, S, Morshed, M, Marr, K Cryptococcus gattii: an Emerging Pathogenic Fungus in the Pacific Northwest. Emerging Infectious Diseases 15(8): Datta, K. Bartlett, K, Baer, R, Byrnes, E, Galanis, E, Heitman, J, Hoang, L, Leslie, M, MacDougall, L, Magill, S, Morshed, M, Marr, K Cryptococcus gattii: an Emerging Pathogenic Fungus in the Pacific Northwest. Emerging Infectious Diseases 15(8): Datta, K., Bartlett, KH, Marr, KA Cryptococcus gattii emergence in Western North America: Exploitation of a novel ecological niche. Interdisciplinary Perspectives on Infectious Diseases v. 2009, Article ID , 8 pages. doi: /2009/ Datta, K., Bartlett, KH, Marr, KA Cryptococcus gattii emergence in Western North America: Exploitation of a novel ecological niche. Interdisciplinary Perspectives on Infectious Diseases v. 2009, Article ID , 8 pages. doi: /2009/ Galanis, E, Hoang, L, Kibsey, P, Morshed, M, Phillips, P Clinical presentation, diagnosis and managment of Cryptococcus gattii cases: Lessons learned from British Columbia. Can J Infect Dis Med Microbiol 20(1): Galanis, E, Hoang, L, Kibsey, P, Morshed, M, Phillips, P Clinical presentation, diagnosis and managment of Cryptococcus gattii cases: Lessons learned from British Columbia. Can J Infect Dis Med Microbiol 20(1): Fyfe, M, MacDougall, L, Romney, M, Starr, M, Pearce M, Mak, S, Mithani, S, Kibsey, P Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: Emergence of a tropical fungus in a temperate environment. CCDR 34(6): 1 – 12. Fyfe, M, MacDougall, L, Romney, M, Starr, M, Pearce M, Mak, S, Mithani, S, Kibsey, P Cryptococcus gattii infections on Vancouver Island, British Columbia, Canada: Emergence of a tropical fungus in a temperate environment. CCDR 34(6): 1 – 12. Chambers, C, MacDougall, L, Li, M, Galanis, E Using tourism data to define specific risk areas for Cryptococcus gattii on Vancouver Isalnd, Canada. Emerg Infecg Dis 14(11): 1781 – 3. Chambers, C, MacDougall, L, Li, M, Galanis, E Using tourism data to define specific risk areas for Cryptococcus gattii on Vancouver Isalnd, Canada. Emerg Infecg Dis 14(11): 1781 – 3. Bartlett, KH, Kidd, SE, Kronstad, J The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1): Bartlett, KH, Kidd, SE, Kronstad, J The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Infectious Disease Reports, 10(1): Nicol, A-M, Hurrell, C, McDowall, W, Bartlett, K, Elmieh, N Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii. Journal of Risk Analysis 28(2): Nicol, A-M, Hurrell, C, McDowall, W, Bartlett, K, Elmieh, N Communicating the risks of a new, emerging pathogen: the case of Cryptococcus gattii. Journal of Risk Analysis 28(2): doi: /j x. Bartlett, KH,, Kronstad, J The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Fungal Infection Reports, 1: Bartlett, KH, Kidd, SE, Kronstad, J The emergence of Cryptococcus gattii in British Columbia and the Pacific Northwest. Current Fungal Infection Reports, 1: Upton, A, Fraser, JA, Kidd, SE, Bretz, C, Heitman, J, Bartlett, KH, Raverty, S. Marr, KA First Contemporary Case of Human Infection with Cryptococcus gattii in Puget Sound: Evidence for Spread of the Vancouver Island Outbreak. Journal of Clinical Microbiology, 45(9): Upton, A, Fraser, JA, Kidd, SE, Bretz, C, Heitman, J, Bartlett, KH, Raverty, S. Marr, KA First Contemporary Case of Human Infection with Cryptococcus gattii in Puget Sound: Evidence for Spread of the Vancouver Island Outbreak. Journal of Clinical Microbiology, 45(9): Kidd, SE, Chow, Y, Mak, S, Bach, PJ, Chen, H, Hingston, AO, Kronstad, JW, and Characterization of Environmental Sources of Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest. Applied and Environmental Microbiology, 73 (5):1433 – Kidd, SE, Chow, Y, Mak, S, Bach, PJ, Chen, H, Hingston, AO, Kronstad, JW, and Bartlett, KH Characterization of Environmental Sources of Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest. Applied and Environmental Microbiology, 73 (5):1433 – 1443.

MacDougall, L, Kidd, SE, Galanis, E., Mak, S., Leslie, MJ, Cieslak, PR, Kronstad, JW, Morshed, MG, and Bartlett, KH Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerging Infectious Diseases 13(1): Kidd, SE, Bach, PJ, Hingston, AO, Mak, S, Chow, Y, MacDougall, L, Kronstad, JW, Bartlett, KH Cryptococcus gattii Dispersal Mechanisms, British Columbia, Canada. Emerging Infectious Diseases 13(1): Duncan, C, Schwantje, H, Stephen, C, Campbell, J, Bartlett K Cryptococcus gattii in wildlife of Vancouver Island, BC, Canada. Journal of Wildlife Diseases 42: Duncan, C, Stephen, C, Lester, S, Bartlett, KH Sub-clinical infection and asymptomatic carriage of Cryptococcus gattii in dogs and cats during an outbreak of cryptococcosis. Medical Mycology 43: Kidd, SE, Guo, H, Bartlett, KH, Kronstad, JW, Xu, J Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eucaryotic Cell 4: Duncan C, Stephen C, Lester S and Bartlett, KH Follow-up study of dogs and cats with asymptomatic Cryptococcus gattii infection or nasal colonization. Medical Mycology 43: Kidd S, Hagen F, Tscharke M, Huynh M, Bartlett KH, Fyfe, M, MacDougall L, Boekhout T, Kwon-Chung KJ, Meyer W A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proceedings of the National Academy of Sciences 101(49): Lester S, Kowalewich N, Bartlett KH, Krockenberger MB, Fairfax, TM, Malik R Clinicopathologic features of cryptococcosis in dogs, cats, ferrets, and a bird: 38 Cases (January to July 2003). Journal of the American Veterinary Medical Association, 225 (11):